Calculation of relative hydration free energy differences for heteroaromatic compounds: Use in the design of adenosine deaminase and cytidine deaminase inhibitors

Journal of the American Chemical Society

Volumn 120, Issue 14, 1998, Pages 3295-3304

  Erion, Mark D ^a   Reddy, M Rami ^a  

^a Metabasis Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CYTIDINE DEAMINASE; ENZYME INHIBITOR;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; COVALENT BOND; ENERGY TRANSFER; ENZYME INHIBITION; EQUILIBRIUM CONSTANT; HYDRATION; NONHUMAN;

EID: 0032522283     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja972906j     Document Type: Article

References (74)

1. Wolfenden, R. Annu. Rev. Biophys. Bioeng. 1976, 5, 271-306.
2. Kati, W. M.; Wolfenden, R. Science 1989, 243, 1591-1593.
3. Gelb, M. H.; Svaren, J. P.; Abeles, R. H. Biochemistry 1985, 24, 1813-1817.
4. Bell, R. P. Adv. Phys. Org. Chem. 1966, 4, 1-29.
5. (a) Wiberg, K. B.; Morgan, K. M.; Maltz, H. J. Am. Chem. Soc. 1994, 116, 11067-11077.
6. (b) Henke, S. L.; Hada, C. M.; Morgan, K. M.; Wiberg, K. B.; Wasserman, H. H. J. Org. Chem. 1993, 58, 2830-2839.
7. Erion, M. D.; Reddy, M. R. J. Comput. Chem. 1995, 12, 1513-1521.
8. (a) Albert, A. Adv. Heterocycl. Chem. 1976, 20, 117-143.
9. (b) Albert, A.; Armarego, W. L. F. Adv. Heterocycl. Chem. 1965, 4, 1-42.
10. (c) Perrin, D. D. Adv. Heterocycl. Chem. 1965, 4, 43-73.
11. (a) Wolfenden, R.; Kaufman, J.; Macon, J. B. Biochemistry 1969, 8, 2412-2415.
12. (b) Kati, W. M.; Acheson, S. A.; Wolfenden, R. Biochemistry 1992, 31, 7356-7366.
13. (a) Cohen, R. M.; Wolfenden, R. J. Biol. Chem. 1971, 246, 7561-7565.
14. (b) Frick, L.; Yang, C.; Marquez, V. E.; Wolfenden, R. Biochemistry 1989, 28, 9423-9430.
15. Jones, W.; Kurz, L. C.; Wolfenden, R. Biochemistry 1989, 28, 1242-1247.
16. (a) Foresman, J. B.; Frisch, A. Exploring Chemistry with Electronic Structure Methods: A Guide to Using Gaussian; Gaussian, Inc.: Pittsburgh, PA, 1993.
17. (b) Hehre, W. J.; Radom, L.; Schleyer, P. v. R.; Pople, J. A. Ab Initio Molecular Orbital Theory; Wiley: New York, 1986.
18. (c) Frisch, M. J.; Head-Gordon, M.; Schlegel, H. B.; Raghavachari, K.; Binkley, J. S.; Gonzalez, C.; Defrees, D. J.; Fox, D. J.; Whiteside, R. J.; Seeger, R.; Melius, C. F.; Baker, J.; Martin, R.; Kahn, L. R.; Stewart, J. J. P.; Fluder, E. M.; Topiol, S.; Pople, J. A. Gaussian92; Gaussian, Inc.: Pittsburgh, PA, 1992.
19. (a) Zwanzig, R. W. J. Chem. Phys. 1954, 22, 1420-1426.
20. (b) Tembe, B. L.; McCammon, J. A. Comput. Chem. 1982, 8, 281-283.
21. (c) Beveridge, D. L.; DiCapua, F. M. Annu. Rev. Biophys. Biophys. Chem. 1989, 18, 431-492.
22. (d) Van Gunsteren, W. F.; Weiner, P. K. Computer Simulation of Biomolecular Systems; ESCOM Science: Leiden, Netherlands, 1989.
23. (e) Molecular Dynamics and Protein Structure; Hermans, J., Ed.; Polycrystal: West Springs, IL, 1985.
24. (f) Reddy, M. R.; Bacquet, R. J.; Varney, M. D. J. Chim. Phys. 1991, 88, 2605-2615.
25. (g) Jorgensen, W. L.; Briggs, J. M. J. Am. Chem. Soc. 1989, 111, 4190-4197.
26. (h) Nagy, P. I.; Durant, G. J.; Smith, D. A. J. Am. Chem. Soc. 1993, 115, 2912-2922.
27. (i) Bash, P. A.; Singh, U. C.; Brown, F. K.; Langridge, R.; Kollman, P. A. Science 1987, 235, 574-575.
28. (j) Cieplak, P.; Bash, P.; Singh, U. C.; Kollman, P. A. J. Am. Chem. Soc. 1987, 109, 6283-6289.
29. (k) Reddy, M. R.; Viswanadhan, V. N.; Weinstein, J. N. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 10287-10291.
30. (a) Weiner, S. J.; Kollman, P. A.; Case, D. A.; Singh, U. C.; Ghio, C.; Alagoha G.; Profeta, S., Jr.; Weiner, P. K. J. Am. Chem. Soc. 1984, 106, 765-784.
31. (b) Singh, U. C.; Weiner, P. K.; Caldwell, J. K.; Kollman, P. A. AMBER Version 3.3; University of California at San Francisco: San Francisco, CA, 1992.
32. (c) Singh, U. C. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4280-4284.
33. (d) Reddy, M. R.; Bacquet, R. J.; Zichi, D.; Mathews, D. A.; Welsh, K. M.; Jones, T. R.; Freer, S. J. Am. Chem. Soc. 1992, 114, 4, 10117-10122.
34. (e) Singh, U. C.; Benkovic, S. J. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 9519-9523.
35. (a) Wilson, D. K.; Rudolph, F. B.; Quiocho, F. A. Science 1991, 252, 1278-1284.
36. (b) Sharff, A. J.; Wilson, D. K.; Chang, Z.; Quiocho, F. A. J. Mol. Biol. 1992, 226, 917-921.
37. (a) Berendsen, H. J. C.; Grigera, J. R.; Straatsma, T. P. J. Phys. Chem. 1987, 91, 6269-6271.
38. (b) Reddy, M. R.; Berkowitz, M. Chem. Phys. Lett. 1989, 155, 173-176.
39. Chirlian, L. E.; Francl, M. M. J. Comput. Chem. 1987, 8, 894-905.
40. Verlet, L. Phys. Rev. 1967, 159, 98-103.
41. Ryckart, J. P.; Ciccotti, G.; Berendsen, H. J. C. J. Comput. Phys. 1977, 23, 327-341.
42. Roberiro da Silva, M. A. V.; Matos, M. A. R.; Morais, V. M. F. J. Chem. Soc., Faraday Trans. 1995, 91, 1907-1910.
43. (a) Perrin, D. D. J. Chem. Soc. 1962, 645-653.
44. (b) Armarego, W. L. F. J. Chem. Soc. 1962, 4094-4103.
45. (c) Albert, A. Angew. Chem., Int. Ed. Engl. 1967, 6, 919-928.
46. 1 is 9999.
47. Biffin, N. E. C.; Brown, D. J.; Sugimoto, T. J. Chem. Soc. C. 1970, 139-145.
48. Perrin, D. D.; Inoue, Y. J. Phys. Chem. 1962, 66, 1689.
49. Clark, J.; Pendergast, W. J. Chem. Soc. C. 1969, 1751-1754.
50. Jones, W.; Wolfenden, R. J. Am. Chem. Soc. 1986, 108, 7444-7445.
51. (a) Albert, A. J. Chem. Soc. C 1966, 427-433.
52. (b) Bunning, J. W.; Perrin, D. D. J. Chem. Soc. C 1966, 433-436.
53. (c) Albert, A. J. Chem. Soc. B 1966, 438-441.
54. Katritzky, A. R.; Kingsland, M.; Tee, O. S. J. Chem. Commun. 1968, 289-290.
55. (a) McCormack, J. J.; Marquez, V. E.; Liu, P. S.; Vistica, D. T.; Driscoll, J. S. Biochem. Pharmacol. 1980, 29, 830-832.
56. (b) Driscoll, J. S.; Marquez, V. E.; Plowman, J.; Liu, P. S.; Kelly, J. A.; Barchi, Jr., J. J. J. Med. Chem. 1991, 34, 3280-3284.
57. (a) Pullman, B.; Pullman, A. Adv. Heterocycl. Chem. 1971, 13, 77.
58. (b) Chenon, M.-T.; Pugmire, R. J.; Grant, D. M.; Panzica, R. P.; Townsend, L. B. J. Am. Chem. Soc. 1975, 97, 4627-4642.
59. (c) Erion, M. D.; Stoeckler, J. D.; Guida, W. C.; Walter, R. L.; Ealick, S. E. Biochemistry 1997, 36, 11735-11748.
60. Agarwal, R. P. Pharmac. Ther. 1982, 17, 399-429.
61. Marquez, V. E. Developments in Cancer Chemotherapy; Glazer, R. I., Ed., CRC: Boca Raton, FL, 1984; pp 91-114.
62. (a) Erion, M. D.; Bookser, B. C.; Kasibhatla, S. R. U.S. Patent 5, 731, 432.
63. (b) Marrone, T. J.; Straatsma, T. P.; Briggs, J. M.; Wilson, D. K.; Quiocho, F. A.; McCammon, J. A. J. Med. Chem. 1996, 39, 277-284.
64. (c) Evans, B.; Wolfenden, R. J. Am. Chem. Soc. 1970, 92, 4751.
65. Wolfenden, R. Acc. Chem. Res. 1972, 5, 10-18.
66. Kurz, L. C.; Frieden, C. Biochemistry 1987, 26, 8450-8457.
67. (a) Betts, L.; Xiang, S.; Short, S. A.; Wolfenden, R.; Carter, C. W. J. Mol. Biol. 1994, 235, 635-656.
68. (b) Xiang, S.; Short, S. A.; Wolfenden, R.; Carter, C. W., Jr. Biochemistry 1995, 34, 4516-4523.
69. (a) The equilibrium constant represents the value obtained using the convention for dilute aqueous solution that treats water as unity.
70. i* is half this value since only the R-stereoisomer is active.
71. 37
72. Shewach, D. S.; Krawczyk, S. H.; Acevedo, O. L.; Townsend, L. B. Biochemical Pharmacology 1992, 44, 1697-1700.
73. (a) Albert, A.; Tratt, K. J. Chem. Soc. C. 1968, 344-347.
74. (b) Albert, A. J. Chem. Soc. C. 1968, 2076-2083.